Your browser doesn't support javascript.
loading
Rational development of a combined mRNA vaccine against COVID-19 and influenza.
Ye, Qing; Wu, Mei; Zhou, Chao; Lu, Xishan; Huang, Baoying; Zhang, Ning; Zhao, Hui; Chi, Hang; Zhang, Xiaojing; Ling, Dandan; Zhang, Rong-Rong; Li, Zhuofan; Luo, Dan; Huang, Yi-Jiao; Qiu, Hong-Ying; Song, Haifeng; Tan, Wenjie; Xu, Ke; Ying, Bo; Qin, Cheng-Feng.
Afiliação
  • Ye Q; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Wu M; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Zhou C; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Lu X; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Huang B; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang N; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Zhao H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Chi H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Zhang X; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Ling D; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Zhang RR; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Li Z; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Luo D; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Huang YJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Qiu HY; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
  • Song H; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Tan W; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. tanwj@ivdc.chinacdc.cn.
  • Xu K; State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, 430072, China.
  • Ying B; Suzhou Abogen Biosciences Co., Ltd., Suzhou, 215123, China.
  • Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China. qincf@bmi.ac.cn.
NPJ Vaccines ; 7(1): 84, 2022 Jul 26.
Article em En | MEDLINE | ID: mdl-35882870
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China